Amanote Research
Register
Sign In
Abstracts of the NIH-FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications”
Disease Markers
- Egypt
doi 10.1155/1998/698239
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
Date
January 1, 1998
Authors
Unknown
Publisher
Hindawi Limited
Related search
Surrogate Endpoints for Efficacy in Clinical Research: Working Definitions and Validation
AACR Education book
Statistical Evaluation of Surrogate Endpoints in Clinical Studies
A Perspective on Surrogate Endpoints in Controlled Clinical Trials
Statistical Methods in Medical Research
Health Information Management
Epidemiology
Statistics
Probability
Prm1 - Validation of Alternative “Surrogate” Clinical Endpoints in Advanced Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Defining Surrogate Endpoints for Clinical Trials in Severe Falciparum Malaria
PLoS ONE
Multidisciplinary
Methodologic Issues in the Validation of Putative Biomarkers and Surrogate Endpoints in Treatment Evaluation for Systemic Lupus Erythematosus
Endocrine, Metabolic and Immune Disorders - Drug Targets
Endocrinology
Allergy
Immunology
Metabolism
Diabetes
Clinical/Research Abstracts Accepted for Presentation at the AAFP World Feline Conference 2019
Journal of Feline Medicine and Surgery
Small Animals
Clinical/Research Abstracts Accepted for Presentation at the AAFP World Feline Conference 2019
Journal of Feline Medicine and Surgery
Small Animals
Abstracts From the NCCN 20th Annual Conference: Advancing the Standard of Cancer Care™
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
